Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (461-470 of 491) with videos related to

Pageof 50
Sort By:
The British Journal of Dermatology|August 25, 2015
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelinesJ E Mellerio, S J Robertson, C Bernardis, et al.
The Journal of Investigative Dermatology|April 10, 2009
Reliability and convergent validity of two outcome instruments for pemphigusMisha Rosenbach, Dedee F Murrell, Jean-Claude Bystryn, et al.
The British Journal of Dermatology|June 6, 2023
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb studyLeon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, et al.
Journal of the American Academy of Dermatology|April 3, 2014
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classificationJo-David Fine, Leena Bruckner-Tuderman, Robin A J Eady, et al.
The British Journal of Dermatology|February 5, 2020
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragilityC Has, J W Bauer, C Bodemer, et al.
International Journal of Dermatology|July 21, 2025
Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering DiseasesPavel V Chernyshov, Andrew Y Finlay, Aikaterini Patsatsi, et al.
Annals of the Rheumatic Diseases|July 31, 2016
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysisEli M Miloslavsky, Ray P Naden, Johannes W J Bijlsma, et al.
The British Journal of Dermatology|July 3, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 TrialsLinda Stein Gold, April W Armstrong, Jennifer Soung, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 21, 2022
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International SurveyMarine Guignant, Billal Tedbirt, Dedee F Murrell, et al.
The Journal of Investigative Dermatology|March 23, 2012
Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgarisOfer Sarig, Sivan Bercovici, Lilach Zoller, et al.
Pageof 50

Showing results (461-470 of 491) with videos related to

Sort By:
Pageof 50
The British Journal of Dermatology|August 25, 2015
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelinesJ E Mellerio, S J Robertson, C Bernardis, et al.
The Journal of Investigative Dermatology|April 10, 2009
Reliability and convergent validity of two outcome instruments for pemphigusMisha Rosenbach, Dedee F Murrell, Jean-Claude Bystryn, et al.
The British Journal of Dermatology|June 6, 2023
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb studyLeon H Kircik, Javier Alonso-Llamazares, Neal Bhatia, et al.
Journal of the American Academy of Dermatology|April 3, 2014
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classificationJo-David Fine, Leena Bruckner-Tuderman, Robin A J Eady, et al.
The British Journal of Dermatology|February 5, 2020
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragilityC Has, J W Bauer, C Bodemer, et al.
International Journal of Dermatology|July 21, 2025
Quality of Life Measurement in Autoimmune Blistering Diseases: Mutual Position Statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Autoimmune Blistering DiseasesPavel V Chernyshov, Andrew Y Finlay, Aikaterini Patsatsi, et al.
Annals of the Rheumatic Diseases|July 31, 2016
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysisEli M Miloslavsky, Ray P Naden, Johannes W J Bijlsma, et al.
The British Journal of Dermatology|July 3, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 TrialsLinda Stein Gold, April W Armstrong, Jennifer Soung, et al.
JID Innovations : Skin Science From Molecules to Population Health|July 21, 2022
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International SurveyMarine Guignant, Billal Tedbirt, Dedee F Murrell, et al.
The Journal of Investigative Dermatology|March 23, 2012
Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgarisOfer Sarig, Sivan Bercovici, Lilach Zoller, et al.
Pageof 50